UNSPSC 51434933: Guanethidine/hydrochlorothiazide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434933 Guanethidine/hydrochlorothiazide is a Commodity code that in practice encompasses emergency medical pharmaceuticals and injectable medications sourced by state and local public safety agencies. Rather than the specific antihypertensive combination named in the code itself, recent state and local solicitations under this code reflect demand for Advanced Life Support (ALS) medications used in emergency response — epinephrine, adenosine, diltiazem, labetalol, and similar injectables stocked and administered by fire rescue services. The issuing bodies are primarily municipal fire departments and emergency medical services bureaus operating under city purchasing departments. Vendors supply these medications in unit quantities specified for annual or multi-year standing agreements, with strict expiration-date requirements (typically nine months or longer from acceptance) and rapid delivery timelines (often ten days or fewer). Contracts typically include product warranty periods, arrangements for expired-material pickup and replacement, and compliance obligations under OSHA Hazard Communication Standards for safety data sheets.

The City of Tampa's Purchasing Department posted an IFB for Advanced Life Support Medications (Solicitation 26P00188, due April 8, 2026) valued at $40,000.00, requiring four specific medication line items — Labetalol, Epinephrine, Adenosine, and Diltiazem — for Tampa Fire Rescue in Hillsborough County, Florida. The solicitation carried a Small Local Business Enterprise sheltered market designation with a 5 percent bid discount (not to exceed $10,000) and required Safety Data Sheets and WCAG 2.2 Level AA accessibility documentation. The contract term runs one year from award with two optional one-year renewals plus unilateral extension rights for three additional 30-day periods. Geographic activity in recent months is limited to the Tampa, Florida region in the source provided; no other states or jurisdictions appear in the opportunity record.